BVS 11.69 (+2.81%)
US09075A1088Medical Diagnostics & ResearchDiagnostics & Research

Bioventus (BVS) Competitor Comparison

We are evaluating the key criteria listed to compare Bioventus (BVS) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - BVS ranking 35 / 58

These are the competitors of Bioventus in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
70.97
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. DarioHealth DRIO
31.71
4. Myriad Genetics MYGN
29.51
5. Syneos Health SYNH
24.79
6. Heska HSKA
15.42
7. Trinity Biotech TRIB
13.63
8. CareDx CDNA
11.15
9. Inotiv NOTV
11.05
10. NeoGenomics NEO
10.05
11. Olink Holding OLK
8.53
12. Anixa Biosciences ANIX
8.08
13. Charles River Laboratories CRL
7.53
14. Pacific Biosciences of California PACB
7.2
15. Fulgent Genetics FLGT
7
16. Qiagen QGEN
6.82
17. Aspira Womens Health AWH
5.9
18. DexCom DXCM
5.76
19. Twist Bioscience TWST
5.67
20. Exact Sciences EXAS
5.43
21. Waters WAT
5.21
22. PerkinElmer PKI
4.97
23. Sotera Health SHC
4.56
24. Laboratory Corp of America Holdings LH
4.48
25. Quest Diagnostics DGX
4.35
26. Illumina ILMN
4.12
27. Guardant Health GH
3.91
28. IQVIA Holdings IQV
3.85
29. Neogen NEOG
3.53
30. Agilent Technologies A
3.26
31. Sera Prognostics SERA
3.23
32. National Research NRC
3.16
33. IDEXX Laboratories IDXX
3.09
34. Personalis PSNL
3.07
35. Bioventus BVS
3
36. Enzo Biochem ENZ
2.89
37. Psychemedics PMD
2.76
38. Mettler-Toledo MTD
2.65
39. Precipio PRPO
2.36
40. Interpace Biosciences IDXG
2.33
41. Neuronetics STIM
2.28
42. Exagen XGN
2.26
43. Global Cord Blood CO
2.23
44. Thermo Fisher Scientific TMO
2.14
45. MDxHealth MDXH
2.13
46. MaxCyte MXCT
2.11
47. Icon ICLR
2.1
48. Danaher DHR
2.03
49. Biodesix BDSX
1.99
50. Prenetics Global PRE
1.84
51. bioAffinity Technologies BIAF
1.63
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.42
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.74
56. Medpace Holdings MEDP
0.51
57. RadNet RDNT
0.36
58. Lantheus Holdings LNTH
0.3

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.